Laurence Tisi, Co-founder of Lumora, has been leading operations since 2003 and CEO since 2007, directing the R&D pipeline and day to day running of the company. He has helped Lumora raise £4.3M via three rounds of equity funding, generated £1.3M in revenue and over £500K in grant money. Laurence is driving the 'collaborative out-licensing' business model of the company, as it expands into the clinical sector. He is a former winner of the 'Marlene Deluca Prize' for the research he performed on bioluminescence whilst at Cambridge University. He is a named inventor on several patents including Lumora's core 'BART' technology.
Winner of the Ernst & Young Entrepreneur of the Year for Science and Technology in 2005, Jim has had a successful international career in the pharmaceutical and biotechnology industries. A Biochemist and Pharmacologist by training, Jim developed his international career in blue-chip organisations including Roche and Chiron, progressing from the research bench to business management before returning to Scotland in 1999. Jim was instrumental in the formation and development of more than 10 companies in the sector and has successfully exited from 3 of these companies, including the highly acclaimed sale of Haptogen to Wyeth.
David is a co-founder of Circadia Ventures LLP which manages Tate & Lyle Ventures LP a London-based fund backed by the global food ingredients company Tate & Lyle. He has a background in investment banking with a specific focus on the food industry. David spent 14 years as an equity reasearch analyst specifically focused on the food processing industry before co-founding Stamford Partners in 1998. Stamford Partners is a leading investment banking firm providing merger & acquisition and strategic consulting services to the European food industry. David has also held several senior management positions in the European equities operations of NatWest Markets and Banc of America Securities, as well as acting as a consultant to HSBC and the VC industry. Currently he serves on the Boards of Fugeia NV and BioFilm Holdings Ltd. as well as Lumora.
Simon Barnes is a co-founder of Circadia Ventures LLP which manages Tate & Lyle Ventures LP a London-based fund backed by the global food ingredients company Tate & Lyle. He has a background in life sciences venture capital, first with the London office of Atlas Venture and subsequently with GIMV Venture Capital. He has focused throughout his career on investing in university spin-outs and in addition to Lumora, currently serves on the Boards of Aquapharm Biodiscovery Ltd, Allylix Inc., and Fugeia NV as Chairman. Simon was trained as a plant biochemist and has a first class honours degree in Natural Sciences and a PhD from Cambridge University. He spent two years as a NATO Research Fellow at The Rockefeller University in New York. He holds an MBA with Distinction from Imperial College London where he later served on the Faculty.
Ian Johnson joined the Board of Lumora in April 2008. From 1999 until 2006, he was Chief Executive Officer of Biotrace International plc, a leading provider of microbiology related testing systems and reagents. Biotrace became a public company in 1993 and was listed on the main market of the London Stock Exchange until its acquisition by 3M in December 2006. Mr Johnson is also Chairman of Finance Wales and Chairman and Deputy Chairman respectively of Evans Analytical Group and AOI Medical Inc. both AIM listed companies. Mr. Johnson studied at University College Cardiff obtaining an Honours Degree and a M.Sc. by thesis in Microbiology. He is the author of numerous publications and patents in the field of rapid microbiology.
Ed Wass is an Investment Director at Catapult, having joined the firm in March 2009. Ed started his career with PricewaterhouseCoopers in London, which included five years working in business recovery. Ed then participated in the BIMBO of a Leicester based marketing agency which was successfully sold in 2007. Immediately prior to joining Catapult Ed was the Interim Finance Director of a number of businesses including The CarbonNeutral Company. He has an honours degree from The University of Nottingham and is a qualified Chartered Accountant. Recent investments that Ed has been involved in include Accutronics, Crystallon and Lumora.